Celularity Inc

General ticker "CELU" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $38.4B

Celularity Inc does not follow the US Stock Market performance with the rate: -14.1%.

Estimated limits based on current volatility of 3.3%: low 2.21$, high 2.36$

Factors to consider:

  • Earnings expected soon, date: 2025-01-07 bmo
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.33$, 4.72$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.26$, 6.41$]

Financial Metrics affecting the CELU estimates:

  • Negative: Non-GAAP EPS, $ of -2.66 <= 0.10
  • Negative: Operating profit margin, % of -89.41 <= 1.03
  • Negative: Operating cash flow per share per price, % of -51.89 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term CELU quotes

Long-term CELU plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $21.34MM $17.98MM $22.77MM
Operating Expenses $130.39MM $43.58MM $215.06MM
Operating Income $-109.06MM $-25.60MM $-192.29MM
Non-Operating Income $8.96MM $39.80MM $-4.00MM
Interest Expense $3.17MM $0.00MM $3.02MM
R&D Expense $88.35MM $78.36MM $30.46MM
Income(Loss) $-100.10MM $14.21MM $-196.28MM
Taxes $0.02MM $0.01MM $0.01MM
Profit(Loss) $-100.12MM $14.19MM $-196.29MM
Stockholders Equity $99.42MM $198.90MM $40.96MM
Assets $414.13MM $401.07MM $143.89MM
Operating Cash Flow $-110.10MM $-137.88MM $-38.69MM
Capital expenditure $6.20MM $5.24MM $4.05MM
Investing Cash Flow $-5.90MM $-5.24MM $-4.05MM
Financing Cash Flow $98.56MM $119.84MM $24.09MM
Earnings Per Share* $-8.04 $1.01 $-11.02

* EPS are Split Adjusted, recent splits may be reflected with a delay.